Prolonging Gastrointestinal-Stromal-Tumor-free life, an optimal suggestion of imatinib intervention ahead of operation
Conclusion: In conclusion, as for regressing tumor progression and creating operative chance, preoperative imatinib should be considered for the patients with high risk, although the precise duration of this intervention needs further validation.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Lin-Hai Yan, Zhi-Ning Chen, Chun-Jun Li, Jia Chen, Yu-Zhou Qin, Jian-Si Chen, Wei-Zhong Tang Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Genetics | Gleevec | Leukemia | Study